This reactive pattern forms a central litigation theme: that manufacturers waited for definitive proof of harm through patient injuries rather than exercising caution when early warning signals appeared
Three different tests: Tendon outgrowth , how many cells grow out from a piece of tendon in the dish Wound healing assay , cells are grown as a monolayer, you make a scratch in it and observe how quickly it closes Cell survival , you add peroxide (oxidative stress, which normally kills cells) and observe how many survive What they found: Tenocytes grew faster and in a dose-dependent curve (the more BPC-157, the more growth) The scratch closed 1.8 faster at 1 g/ml BPC-157 Under oxidative stress, 22 % of cells survived without BPC-157, but 67 % with BPC-157 When they blocked the FAK enzyme, the effect disappeared mechanism confirmed Why it matters: This is not just a systemic effect via blood, BPC-157 directly modifies the biology of an individual cell
If you have had black stool for a long duration, observe liver flukes in stool, or notice blood clots in the stool, then consult a doctor
In future, once data are available on a larger number of patients switching treatments, the use of administrative claims data in similar analyses would help to increase confidence that the patients represented are those who have collected and adhered to treatment following switching
